DSpace Repository

Browsing by Author "Hacibekiroglu, I"

Browsing by Author "Hacibekiroglu, I"

Sort by: Order: Results:

  • The role of the gastrectomy on survival in metastatic gastric cancer 
    Yazici, O; Ozdemir, N; Duran, AO; Menekse, S; Sendur, MAN; Karaca, H; Goksel, G; Arpaci, E; Eren, T; Hacibekiroglu, I; Bilgetekin, I; Kacan, T; Ozkan, M; Aksoy, S; Aksoy, A; Zengin, N (2015)
  • Evaluation of prognostic factors in localized high-grade 
    Ozcelik, M; Seker, M; Eraslan, E; Koca, S; Yazilitas, D; Ercelep, O; Ozaslan, E; Kaya, S; Hacibekiroglu, I; Menekse, S; Aksoy, A; Taskoylu, BY; Varol, U; Arpaci, E; Ciltas, A; Oksuzoglu, B; Zengin, N; Gumus, M; Aliustaoglu, M (2016)
    Most data on prognostic factors for patients with high-grade undifferentiated pleomorphic sarcoma (HGUPS) is obtained from analyses of soft tissue sarcomas. The purpose of this study was to evaluate the clinicopathologic ...
  • The effect of the gastrectomy on survival in patients with metastatic 
    Yazici, O; Ozdemir, N; Duran, AO; Menekse, S; Ali, M; Sendur, N; Karaca, H; Goksel, G; Arpaci, E; Hacibekiroglu, I; Bilgetekin, I; Kacan, T; Ozkan, M; Aksoy, S; Aksoy, A; Cokmert, S; Uysal, M; Elkiran, ET; Cicin, I; Buyukberber, S; Zengin, N (2016)
    Aim: To investigate the role of surgical resection of primary tumor on overall survival (OS) in advanced gastric cancer patients at the time of diagnosis. Patients & methods: The survival rates of metastatic gastric cancer ...
  • Evaluation of prognostic factors in localized high-grade 
    Ozcelik, M; Seker, M; Eraslan, E; Koca, S; Yazilitas, D; Ercelep, O; Ozaslan, E; Kaya, S; Hacibekiroglu, I; Menekse, S; Aksoy, A; Taskoylu, BY; Varol, U; Arpaci, E; Ciltas, A; Oksuzoglu, B; Zengin, N; Gumus, M; Aliustaoglu, M (2016)
    Most data on prognostic factors for patients with high-grade undifferentiated pleomorphic sarcoma (HGUPS) is obtained from analyses of soft tissue sarcomas. The purpose of this study was to evaluate the clinicopathologic ...
  • Evaluation of prognostic factors in localized high-grade 
    Ozcelik, M; Seker, M; Eraslan, E; Koca, S; Yazilitas, D; Ercelep, O; Ozaslan, E; Kaya, S; Hacibekiroglu, I; Menekse, S; Aksoy, A; Taskoylu, BY; Varol, U; Arpaci, E; Ciltas, A; Oksuzoglu, B; Zengin, N; Gumus, M; Aliustaoglu, M (2016)
    Most data on prognostic factors for patients with high-grade undifferentiated pleomorphic sarcoma (HGUPS) is obtained from analyses of soft tissue sarcomas. The purpose of this study was to evaluate the clinicopathologic ...
  • The effect of the gastrectomy on survival in patients with metastatic 
    Yazici, O; Ozdemir, N; Duran, AO; Menekse, S; Ali, M; Sendur, N; Karaca, H; Goksel, G; Arpaci, E; Hacibekiroglu, I; Bilgetekin, I; Kacan, T; Ozkan, M; Aksoy, S; Aksoy, A; Cokmert, S; Uysal, M; Elkiran, ET; Cicin, I; Buyukberber, S; Zengin, N (2016)
    Aim: To investigate the role of surgical resection of primary tumor on overall survival (OS) in advanced gastric cancer patients at the time of diagnosis. Patients & methods: The survival rates of metastatic gastric cancer ...
  • Prognostic factors of patients who received chemotherapy after cranial 
    Inal, A; Kodaz, H; Odabas, H; Duran, AO; Seker, MM; Inanc, M; Elkiran, ET; Gunaydin, Y; Menekse, S; Topcu, TO; Urakci, Z; Tastekin, D; Bilici, M; Cihan, S; Geredeli, C; Sezer, E; Uncu, D; Arpaci, E; Ozturk, B; Bal, O; Uysal, M; Tanriverdi, O; Gumus, M; Ustaalioglu, BBO; Suner, A; Cokmert, S; Hacibekiroglu, I; Aydin, K; Isikdogan, A (2018)
    Purpose: Almost half of all patients diagnosed with non-small cell lung cancer (NSCLC) have distant metastases at presentation. One-third of patients with NSCLC will have brain metastases. Without effective treatment, the ...
  • Prognostic factors of patients who received chemotherapy after cranial 
    Inal, A; Kodaz, H; Odabas, H; Duran, AO; Seker, MM; Inanc, M; Elkiran, ET; Gunaydin, Y; Menekse, S; Topcu, TO; Urakci, Z; Tastekin, D; Bilici, M; Cihan, S; Geredeli, C; Sezer, E; Uncu, D; Arpaci, E; Ozturk, B; Bal, O; Uysal, M; Tanriverdi, O; Gumus, M; Ustaalioglu, BBO; Suner, A; Cokmert, S; Hacibekiroglu, I; Aydin, K; Isikdogan, A (2018)
    Purpose: Almost half of all patients diagnosed with non-small cell lung cancer (NSCLC) have distant metastases at presentation. One-third of patients with NSCLC will have brain metastases. Without effective treatment, the ...
  • The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab 
    Ozdemir, O; Zengel, B; Yildiz, Y; Uluc, BO; Cabuk, D; Ozden, E; Salim, DK; Paydas, S; Demir, A; Diker, O; Pilanci, KN; Sonmez, OU; Vatansever, S; Dogan, I; Gulmez, A; Cakar, B; Gursoy, P; Yildirim, ME; Ayhan, M; Karadurmus, N; Aykan, MB; Cevik, GT; Sakalar, T; Hacibekiroglu, I; Gulbagci, BB; Dincer, M; Garbioglu, DB; Kemal, Y; Nayir, E; Taskaynatan, H; Yilmaz, M; Avci, O; Sari, M; Coban, E; Atci, MM; Esen, SA; Telli, TA; Karatas, F; Inal, A; Demir, H; Kalkan, NO; Yilmaz, C; Tasli, F; Alacacioglu, A (2022)
    In our study, we aimed to evaluate the pathological response rates and side effect profile of adding pertuzumab to the treatment of HER2+ locally advanced, inflammatory, or early-stage breast cancer. This study was conducted ...
  • Efficacy and safety profile of COVID-19 vaccine in cancer patients: a 
    Yasin, AI; Aydin, SG; Sumbul, B; Koral, L; Simsek, M; Geredeli, C; Ozturk, A; Perkin, P; Demirtas, D; Erdemoglu, E; Hacibekiroglu, I; Cakir, E; Tanrikulu, E; Coban, E; Ozcelik, M; Celik, S; Teker, F; Aksoy, A; Firat, ST; Tekin, O; Kalkan, Z; Turken, O; Oven, BB; Dane, F; Bilici, A; Isikdogan, A; Seker, M; Turk, HM; Gumus, M (2022)
    Aim: To compare the seropositivity rate of cancer patients with non-cancer controls after inactive SARS-CoV-2 vaccination (CoronaVac) and evaluate the factors affecting seropositivity. Method: Spike IgG antibodies against ...
  • Prognostic factors of perioperative FLOT regimen in operable gastric and 
    Erol, C; Sakin, A; Basoglu, T; Ozden, E; Cabuk, D; Dogan, M; Oksuzoglu, B; Yildirim, HC; Oner, I; Eryilmaz, MK; Dulgar, O; Aydin, D; Dogan, N; Ozen, M; Hacibekiroglu, I; Ozdemir, N; Gurler, F; Paksoy, N; Karabulut, S; Aksoy, A; Hizal, M; Kahraman, S; Sen, E; Paydas, S; Cilbir, E; Firat, F; Akdeniz, N; Ozcelik, M; Oyman, A; Baytemur, NK; Acar, R; Almuradova, E; Karabulut, B; Sakalar, T; Arak, H; Degerli, E; Turker, S; Alan, O; Er, O; Tasci, ES; Demir, N; Cavdar, E; Turhal, S; Dede, DS; Akinci, MB; Yalcin, B; Yumuk, F; Yalcin, S; Sendur, MAN (2022)
    Background/aim: Perioperative FLOT regimen is a standard of care in locally advanced operable gastric and GEJ adenocarcinoma. We aimed to determine the efficacy, prognostic factors of perioperative FLOT chemotherapy in ...
  • The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab 
    Ozdemir, O; Zengel, B; Yildiz, Y; Uluc, BO; Cabuk, D; Ozden, E; Salim, DK; Paydas, S; Demir, A; Diker, O; Pilanci, KN; Sonmez, OU; Vatansever, S; Dogan, I; Gulmez, A; Cakar, B; Gursoy, P; Yildirim, ME; Ayhan, M; Karadurmus, N; Aykan, MB; Cevik, GT; Sakalar, T; Hacibekiroglu, I; Gulbagci, BB; Dincer, M; Garbioglu, DB; Kemal, Y; Nayir, E; Taskaynatan, H; Yilmaz, M; Avci, O; Sari, M; Coban, E; Atci, MM; Esen, SA; Telli, TA; Karatas, F; Inal, A; Demir, H; Kalkan, NO; Yilmaz, C; Tasli, F; Alacacioglu, A (2022)
    In our study, we aimed to evaluate the pathological response rates and side effect profile of adding pertuzumab to the treatment of HER2+ locally advanced, inflammatory, or early-stage breast cancer. This study was conducted ...
  • Real life experience of patients with locally advanced gastric and 
    Basoglu, T; Sakin, A; Erol, C; Ozden, E; Cabuk, D; Cilbir, E; Ozyukseler, DT; Ayhan, M; Sendur, MA; Dogan, M; Oksuzoglu, B; Eryilmaz, MK; Er, O; Tasci, ES; Ozyurt, N; Dulgar, O; Ozen, M; Hacibekiroglu, I; Oner, I; Bekmez, ET; Yildirim, HC; Yalcin, S; Paydas, S; Yekeduz, E; Aksoy, A; Ozcelik, M; Oyman, A; Almuradova, E; Karabulut, B; Demir, N; Dincer, M; Ozdemir, N; Erdem, D; Ak, N; Inal, A; Salim, DK; Deniz, GI; Sakalar, T; Gulmez, A; Kacan, T; Ozdemir, O; Alan, O; Unal, C; Karakas, Y; Turhal, S; Yumuk, PF
    Neoadjuvant chemotherapy (NACT) in gastroesophageal junction (GEJ) and gastric cancer (GC) was shown to improve survival in recent studies. We aimed to share our real-life experience of patients who received NACT to compare ...
  • Real life experience of patients with locally advanced gastric and 
    Basoglu, T; Sakin, A; Erol, C; Ozden, E; Cabuk, D; Cilbir, E; Ozyukseler, DT; Ayhan, M; Sendur, MA; Dogan, M; Oksuzoglu, B; Eryilmaz, MK; Er, O; Tasci, ES; Ozyurt, N; Dulgar, O; Ozen, M; Hacibekiroglu, I; Oner, I; Bekmez, ET; Yildirim, HC; Yalcin, S; Paydas, S; Yekeduz, E; Aksoy, A; Ozcelik, M; Oyman, A; Almuradova, E; Karabulut, B; Demir, N; Dincer, M; Ozdemir, N; Erdem, D; Ak, N; Inal, A; Salim, DK; Deniz, GI; Sakalar, T; Gulmez, A; Kacan, T; Ozdemir, O; Alan, O; Unal, C; Karakas, Y; Turhal, S; Yumuk, PF
    Neoadjuvant chemotherapy (NACT) in gastroesophageal junction (GEJ) and gastric cancer (GC) was shown to improve survival in recent studies. We aimed to share our real-life experience of patients who received NACT to compare ...